Close Menu

ACLA

Multiplicom said this week that it has appointed Ian Gilham as chairman of the board. Gilham was first COO, then CEO of in vitro diagnostics company Axis-Shield until it was acquired by Alere in November 2011.

NEW YORK (GenomeWeb News) – A group representing US clinical laboratory service providers has submitted a petition asking the US Food and Drug Administration to not regulate lab-developed tests, charging that the agency lacks the legal authority to do so.

NEW YORK (GenomeWeb News) – Due to the challenges of using the gap-fill process to price molecular diagnostics with new CPT codes, some Medicare contractors are delaying payment for tests.

Originally published Oct. 1.
A new bill strongly supported within the diagnostics industry could put pressure on the Centers for Medicare & Medicaid Services to alter its procedures for setting reimbursement rates for molecular diagnostics.

At a meeting hosted by the Centers for Medicare & Medicaid Services this week to determine payment levels for genetic tests placed in the clinical laboratory fee schedule, lab industry professionals remained at loggerheads with pathologists who maintained that the physician f

This article was updated on Oct. 17 to note that Rep. Burgess has introduced the bill and to indicate that the legislation has support from two large laboratories. Originally published Oct. 14.
By Turna Ray

Pages

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.